Physician profile
Robyn D Dauerman
NPI 1215480488
$1,133.22
in general payments reported to CMS, 2019-2025
19 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $169 · 2023: $319 · 2024: $203 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.63 | 2021-2025 | |
| Astellas Pharma US INC | $213.31 | 2021-2024 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $106.71 | 2023-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $82.50 | 2021-2025 | Solosec, Phexx, Phexxi |
| Hologic Sales and Service, LLC | $80.87 | 2021-2025 | Aptima |
| Pfizer INC. | $39.78 | 2021-2024 | |
| Myovant Sciences INC. | $33.35 | 2022 | |
| Bluewind Medical | $31.07 | 2025 | Revi |
| Laborie Medical Technologies Corp. | $28.68 | 2023 | |
| Mayne Pharma Commercial LLC | $24.65 | 2023 | |
| 180 Medical, INC. | $24.29 | 2025 | |
| Kerecis Limited | $22.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Allergan, INC. | $22.70 | 2021 | |
| Therapeuticsmd, INC. | $21.76 | 2021 | |
| Mission Pharmacal Company | $21.33 | 2023-2024 | Uribel Tabs, Citranatal |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20.71 | 2022 | |
| Mylan Pharmaceuticals INC. | $20.33 | 2022 | |
| Lupin INC. | $15.06 | 2021 | |
| Boston Scientific Corporation | $7.73 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Dauerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.